Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Our News

View:
format_list_bulleted grid_view

07/27/2023

CHEPLAPHARM successfully closes acquisition of Zyprexa® portfolio
Press releases
Read more chevron_right

04/28/2023

CHEPLAPHARM places notes in a volume of €750m in challenging market environment
Press releases
Read more chevron_right

04/26/2023

Announcement on Pricing
Press releases
Read more chevron_right

04/24/2023

Announcement on Offering
Press releases
Read more chevron_right

04/22/2023

CHEPLAPHARM announces acquisition of Zyprexa® from Lilly
Press releases
Read more chevron_right

03/01/2023

CHEPLAPHARM strengthens portfolio with asthma treatment from AstraZeneca
Press releases
Read more chevron_right

01/23/2023

CHEPLAPHARM continues expansion in China with the acquisition of XELODA® from Roche
Press releases
Read more chevron_right

02/11/2022

CHEPLAPHARM announces successful pricing of Term Loan B
Investor Relations
Read more chevron_right

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents
Investor Relations
Read more chevron_right

Archive

Back to top expand_less